TRVN: Rega marang bathi kanthi panyesuaian wutah trevena.com
Non-opioid developments and a strong scientific foundation drive the growth of Trevena, Inc. (TRVN). In GURU.Markets, the growth-adjusted P/E confirms this potential, where 0.00 shows the current value of the metric. Management's focus on the commercialization of clinic products complements the strategy, while the neutral geopolitical status of medicine within the US legal framework ensures stability.
Rincian analitis perusahaan Trevena, Inc. (TRVN)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- rincian struktur utang lan likuiditas bisnis:
Rasio Utang marang Ekuitas Trevena, Inc.|TRVN - Utang jangka dawa marang modal|Utang jangka cendhak marang modal trevena.com|TRVN - Gunggung utang perusahaan|Rasio utang marang aset resik Trevena, Inc|TRVN - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Trevena|Rasio likuiditas darurat trevena.com
- rincian asil keuangan lan kelipatan valuasi:
TRVN - Bathi resik|Bathi mangsa ngarep Trevena, Inc.|TRVN - Koefisien rega marang bathi|Kapitalisasi marang proyeksi bathi Trevena Inc|TRVN - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Trevena, Inc|TRVN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Trevena|TRVN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan trevena.com|TRVN - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Trevena, Inc.
Ringkesan analitik perusahaan:Trevena Inc., TRVN
The PEG ratio compares the market value of earnings to their growth rate, allowing for a determination of an asset's fair valuation relative to its expansion. The implementation of software research automation at Trevena, Inc. (TRVN) accelerates data digitization, which is reflected in the P/E ratio relative to EPS dynamics, signaling potential undervaluation and confirming the high resilience of investment capital.
Perusahaan pesaing
BIIB (Biogen Inc) - Koefisien bali modal nimbang wutah|Pangali PEG NBIX (Neurocrine Biosciences Inc)|Regencell Corp (RGC) - Rega marang bathi kanthi panyesuaian wutah|AXSM: Pangali rega marang bathi tumrap wutah|ACAD: Rasio rega marang bathi tumrap wutah|XENE: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Viking Therapeutics Inc (VKTX)|Rasio rega marang bathi tumrap wutah Supernus Pharma|Rasio P/E diaturake wutah CPRX (Catalyst Corp)|Pangali PEG DNLI|Pangali PEG harmonybiosciences.com (HRMY)|Biohaven - Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah AMLX|Trevi Pharma - Pangali PEG|Kapitalisasi marang bathi resik kanthi nimbang wutah Praxis Corp PRAX|Anavex Life Sciences (AVXL) - Rasio rega marang bathi tumrap wutah|Rasio P/E diaturake wutah CBLL|PRTA (Prothena Corporation plc) - Pangali PEG|Pangali rega marang bathi tumrap wutah Alector Therapeutics (ALEC)|Pangali rega marang bathi tumrap wutah ANNX (Annexon Inc.)|Kapitalisasi marang bathi resik kanthi nimbang wutah omeros.com|Neurogene Inc. - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang wutah bathi ACIU (acimmune.com)|VYGR - Rasio rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah NMRA (Neumora)|SCLX (Scilex Holding Co.) - Pangali rega marang bathi tumrap wutah|TVGN (Tevogen Bio Inc.) - Rasio rega marang bathi tumrap wutah|Rasio rega marang bathi tumrap wutah Alpha Cognition Inc|Rasio P/E diaturake wutah CGTX (cogrx.com)|Rasio rega marang bathi tumrap wutah Inhibikase Therapeutics, Inc. (IKT)|Cassava Sciences Inc - Rasio P/E diaturake wutah|Pangali PEG ASRT (Assertio)|Coya Therapeutics Inc (COYA) - Rega marang bathi kanthi panyesuaian wutah|VTGN: Pangali rega marang bathi tumrap wutah|OVID - Pangali PEG|Acumen Pharmaceuticals, Inc. (ABOS) - Rasio rega marang bathi tumrap wutah|CervoMed, Inc. - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Alterity Therapeutics Ltd.|Rega marang bathi kanthi panyesuaian wutah Clene Nanomedicine CLNN|Pangali rega marang bathi tumrap wutah PEPG (PepGen Inc.)|Rasio nilai perusahaan marang wutah bathi JUNS|Rasio rega marang bathi tumrap wutah Relmada Therapeutics, Inc. RLMD|Koefisien bali modal nimbang wutah ANVS|Grace Tx - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Firefly Neuro|KLTO (anewmeds.com) - Pangali rega marang bathi tumrap wutah|NRSN (NeuroSense Therapeutics Ltd.) - Rasio rega marang bathi tumrap wutah|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah MetaVia, Inc. MTVA|Rasio rega marang bathi tumrap wutah NeurAxis, Inc (NRXS)|heliusmedical.com - Rasio P/E diaturake wutah|Pangali PEG PASG (Passage Bio)|Pangali PEG Neuphoria Therapeutics, Inc. NEUP|NERV: Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah ATHA (Athira Pharma Inc)|ADXN: Pangali PEG|ALZN - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Cyclerion Therapeutics Inc.|Rasio P/E diaturake wutah PTIX (Protagenic)|Pangali PEG KTTA|Pangali rega marang bathi tumrap wutah cortigent.com CRGT|Avenue Therapeutics, Inc - Pangali rega marang bathi tumrap wutah|Kapitalisasi marang bathi resik kanthi nimbang wutah BrainStorm Cell Therapeutics Inc. (BCLI)|CARA: Pangali rega marang bathi tumrap wutah|chromocell.com - Rasio nilai perusahaan marang wutah bathi|eliemtx.com (ELYM) - Rasio rega marang bathi tumrap wutah|Intra-Cellular Therapies, Inc. - Koefisien bali modal nimbang wutah|Pangali rega marang bathi tumrap wutah LBPH|Rasio rega marang bathi tumrap wutah MRNS|Rasio rega marang bathi tumrap wutah NKGen Biotech, Inc. (NKGN)|neurobopharma.com - Rasio P/E diaturake wutah|Rasio rega marang bathi tumrap wutah Sage Therapeutics SAGE|SNPX: Rasio P/E diaturake wutah|Vigil Neuro - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Anew Medical Inc.|CERE (Cerevel Therapeutics) - Pangali rega marang bathi tumrap wutah
